IBD

Managing inflammatory bowel disease involves precise diagnosis, vigilant monitoring and strategic treatment ...

AUGUST 25, 2025

The first study in The Regueiro Report this month assesses the efficacy and safety of upadacitinib for people with ...

AUGUST 14, 2025

Many patients with IBD have long attested that alcohol has harmful effects on their condition, and data from a ...

AUGUST 7, 2025

Upadacitinib is safe for adults 50 years of age and older with moderate to severe UC, according to retrospective ...

JULY 29, 2025

Cognitive behavioral therapy decreased pain and improved some measures of sleep in a study of patients with ...

JULY 22, 2025

This month's Regueiro Report looks at one of the most important papers about the epidemiology of IBD to appear for ...

JULY 17, 2025

This month, I focus on different endoscopic techniques that gastroenterologists might use, one for CRC detection in ...

JUNE 30, 2025

Extraintestinal manifestations are common in patients with IBD. They usually appear during the course of IBD, but ...

JUNE 20, 2025

Treatment of IBD often includes dietary modification, which commonly is perceived as a low-risk intervention ...

JUNE 13, 2025

Subcutaneous administration of guselkumab resulted in achievement of all study end points in people with moderate ...

JUNE 9, 2025

Miguel Regueiro, MD, sat down with GEN at DDW 2025 to discuss his favorite abstracts on IBD presented at the ...

JUNE 6, 2025

Maternal IBD is associated with an increased risk for IBD in children, but it may be possible to modify this risk.

JUNE 4, 2025